Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
China
· Delayed Price · Currency is CNY 22.62
+1.71 (8.18%)
At close: Apr 22, 2025, 2:57 PM CST
SHA:688351 Revenue
In the year 2024, Shanghai MicroPort EP MedTech had annual revenue of 413.17M CNY with 25.51% growth. Shanghai MicroPort EP MedTech had revenue of 122.30M in the quarter ending December 31, 2024, with 31.33% growth.
Revenue
413.17M
Revenue Growth
+25.51%
P/S Ratio
24.61
Revenue / Employee
716.06K
Employees
577
Market Cap
10.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 413.17M | 83.97M | 25.51% |
| Dec 31, 2023 | 329.19M | 68.87M | 26.46% |
| Dec 31, 2022 | 260.32M | 70.30M | 36.99% |
| Dec 31, 2021 | 190.03M | 48.74M | 34.50% |
| Dec 31, 2020 | 141.29M | 23.85M | 20.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |